Grade 2 breast cancer means the cancer cells look and behave somewhere between slow-growing (grade 1) and fast-growing (grade 3). It’s the middle category in a three-tier system, and it’s the most common grade pathologists assign. On your pathology report, you may also see it called “moderately differentiated” or “intermediate grade.”
How Grading Works
When a pathologist examines your biopsy or surgical tissue under a microscope, they score the tumor on three features: how much the cells still form the tube-like structures found in normal breast tissue, how abnormal the cell nuclei look compared to healthy cells, and how quickly the cells are dividing. Each feature gets a score from 1 (closest to normal) to 3 (most abnormal), and those three scores are added together for a total between 3 and 9.
A total score of 6 or 7 places the tumor in grade 2. For comparison, a score of 3 to 5 is grade 1, and a score of 8 or 9 is grade 3. This system is called the Nottingham Histologic Score, and it’s the standard method used in pathology labs.
What Grade 2 Cells Look Like
Grade 2 cells sit in a gray zone. They no longer look like normal breast tissue, but they haven’t lost all resemblance to it either. Some tube-like structures may still be present, though they’re disorganized. The nuclei are moderately irregular in size and shape, and the cells are dividing faster than grade 1 but not as rapidly as grade 3. In practical terms, this means the cancer is growing at a moderate pace.
Grade Is Not the Same as Stage
This is one of the most common points of confusion after a diagnosis. Grade describes how the cancer cells look and how fast they’re growing. Stage describes how far the cancer has spread: the size of the tumor, whether lymph nodes are involved, and whether cancer has reached other parts of the body. You can have a small, early-stage tumor that is high grade, or a larger tumor that is low grade. Both pieces of information matter, and your treatment plan will reflect both.
In fact, the current breast cancer staging system incorporates grade alongside tumor size and spread. A grade 2 tumor may be staged differently than a grade 1 tumor of the same size precisely because the grade affects the overall outlook.
How Grade 2 Affects Treatment Decisions
Grade is one of several factors your oncologist uses to build a treatment plan. It sits alongside stage, hormone receptor status (whether the cancer is fueled by estrogen or progesterone), HER2 status, and your overall health. Because grade 2 falls in the middle, treatment decisions can be less straightforward than for clearly slow-growing or clearly aggressive cancers.
For hormone receptor-positive, HER2-negative breast cancer (the most common subtype), grade 2 often creates a genuine question: will chemotherapy provide enough benefit to justify its side effects, or will hormone-blocking therapy alone be sufficient? This is where genomic tests come in. A test like Oncotype DX analyzes the activity of specific genes in the tumor to predict how likely the cancer is to return and how much chemotherapy would reduce that risk. These tests are especially useful for grade 2 tumors because the grade alone doesn’t give a definitive answer.
If the genomic test returns a low score, many people with grade 2 tumors can safely skip chemotherapy and rely on hormone therapy. A high score tips the decision toward adding chemotherapy. For tumors that are hormone receptor-negative or HER2-positive, chemotherapy is generally recommended regardless of grade, because those subtypes tend to behave more aggressively.
What Grade 2 Means for Prognosis
Grade 2 cancers generally carry a prognosis between grade 1 and grade 3, which makes intuitive sense given the scoring. Grade 1 tumors tend to grow slowly and have the most favorable outcomes. Grade 3 tumors grow quickly and are more likely to recur. Grade 2 tumors fall in between, but the range within grade 2 is wide. A tumor that scored a 6 may behave quite differently from one that scored a 7, and hormone receptor status, HER2 status, and lymph node involvement all influence the picture significantly.
This is why oncologists rarely make predictions based on grade alone. It’s one data point in a larger profile. If your pathology report shows grade 2, the most useful next step is understanding how it fits with the rest of your results: your tumor’s receptor status, the size of the tumor, and whether any lymph nodes are involved. Together, those factors give a much clearer picture than any single number on the report.
Reading Your Pathology Report
On a standard pathology report, you’ll typically see the grade listed as “Grade 2” or “G2,” sometimes followed by “moderately differentiated” or the notation “SBR score 6-7.” SBR refers to an older name for the same grading system (Scarff-Bloom-Richardson). You may also see the three individual subscores listed separately, which can give you a sense of whether the tumor sits closer to the grade 1 or grade 3 boundary. A tumor scored 2+2+2 (total 6) is on the lower end of grade 2, while a 3+2+2 (total 7) leans slightly higher.
If your report includes a Ki-67 percentage, that’s a separate measure of how actively the cells are dividing. It’s not part of the Nottingham grade, but it provides additional information about growth speed that your oncologist may factor into treatment planning alongside the grade itself.